Kurt Zinn , PhD
Employment
Professor and Director, Michigan State University, East Lansing, 2017 - Present
Professor, Director, Vice-Chair, University of Alabama at Birmingham, Birmingham, 1995 - 2017
Publications
Clinical Scaleup of Humanized AnnA1 Antibody Yielded Unexpected High Reticuloendothelial (RES) Uptake in Mice Antibodies (2025)
Comparisons of 3D printed materials for biomedical imaging applications Science and Technology of Advanced Materials (2023)
Effective therapy with Bismuth-212 labeled macroaggregated albumin in orthotopic mouse breast tumor models. Frontiers in chemistry (2023)
Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle Therapeutics. Pharmaceutics (2023)
A 3D-printed transfusion platform reveals beneficial effects of normoglycemic erythrocyte storage solutions and a novel rejuvenating solution. Lab on a chip (2022)
Albumin Glycation Affects the Delivery of C-Peptide to the Red Blood Cells. ACS measurement science au (2022)
Biological Distribution and Metabolic Profiles of Carbon-11 and Fluorine-18 Tracers of VX- and Sarin-Analogs in Sprague-Dawley Rats. Chemical research in toxicology (2020)
Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging. Molecular imaging and biology (2020)
Positron emission tomography evaluation of oxime countermeasures in live rats using the tracer O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate [18 F]-VXS. Annals of the New York Academy of Sciences (2020)
Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles. Nanoscale (2020)
